Document is current
Any future updates will be listed below
-
Authors
Tutas, Janine https://orcid.org/0000-0001-5795-3505
Tolve, Marianna https://orcid.org/0000-0002-0893-2967
Özer-Yildiz, Ebru
Ickert, Lotte https://orcid.org/0000-0003-2729-0928
Klein, Ines
Silverman, Quinn https://orcid.org/0000-0003-3660-3199
Liebsch, Filip https://orcid.org/0000-0002-0955-8065
Dethloff, Frederik https://orcid.org/0009-0002-1114-2621
Giavalisco, Patrick https://orcid.org/0000-0002-4636-1827
Endepols, Heike https://orcid.org/0000-0002-6166-4818
Georgomanolis, Theodoros
Neumaier, Bernd https://orcid.org/0000-0001-5425-3116
Drzezga, Alexander https://orcid.org/0000-0001-6018-716X
Schwarz, Guenter https://orcid.org/0000-0002-2118-9338
Thorens, Bernard https://orcid.org/0000-0002-3738-0129
Gatto, Graziana https://orcid.org/0000-0002-4244-8925
Frezza, Christian https://orcid.org/0000-0002-3293-7397
Kononenko, Natalia L. https://orcid.org/0000-0002-3425-6659
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (KO 5091/4-1, DFG-411422114-GRK 2550, EXC 2030–390661388, DFG-431549029–SFB 1451)
iBehave Network financed by the Ministry of Culture and Science of the State of North Rhine-Westphalia.
- License Information
-
More Information
Article History
Received: 2 February 2024
Accepted: 29 November 2024
First Online: 15 January 2025
Competing interests
: A.D. reports the following competing interests: Research support: Siemens Healthineers, Life Molecular Imaging, GE Healthcare, AVID Radiopharmaceuticals, Sofie, Eisai, Novartis/AAA, Ariceum Therapeutics; speaker honorary/advisory boards: Siemens Healthineers, Sanofi, GE Healthcare, Biogen, Novo Nordisk, Invicro, Novartis/AAA, Bayer Vital; stock: Siemens Healthineers, Lantheus Holding, Structured Therapeutics, ImmunoGen; patents: patent for 18F-JK-PSMA- 7 (PSMA PET imaging tracer; patent no. EP3765097A1; date of patent: 20 January 2021). The other authors declare no competing interests.
